ANDREW R. BOLL - 18 Jul 2023 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role: Chief Financial Officer
Signature: /s/ Andrew R. Boll
Issuer symbol: HROW
Transactions as of: 18 Jul 2023
Transactions value $: -$2,485,661
Form type: 4
Filing time: 20 Jul 2023, 19:43:27 UTC
Previous filing: 04 Apr 2023
Next filing: 08 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HROW	Common Stock	Options Exercise		+347K	+106.94%		671K	18 Jul 2023	Direct	F1
transaction	HROW	Common Stock	Tax liability	-$2.49M	-136K	-20.33%	$18.23	534K	18 Jul 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HROW	Performance Stock Unit	Options Exercise	$0	-347K	-100%	$0.00^*	0	18 Jul 2023	Common Stock	347K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The 346,500 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Boll under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 136,350 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 346,500 shares pursuant to the terms of the Incentive Plan.

Content

The 346,500 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Boll under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 136,350 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 346,500 shares pursuant to the terms of the Incentive Plan.